On November 12, 2025 Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, reported that members of company management will participate in the following investor events:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Jefferies London Healthcare Conference
Format: Hybrid presentation (slides & moderated Q&A) and one-on-one investor meetings
Presentation Date/Time: Wednesday, November 19, 2025, at 4:00 PM GMT
Location: London, UK
37th Annual Piper Healthcare Conference
Format: One-on-one investor meetings
Date: December 2-4, 2025
Location: New York, NY
A live webcast of the Jefferies event can be accessed by visiting the "For Investors" page on the Tyra Biosciences website and will be available for replay following the event.
(Press release, Tyra Biosciences, NOV 12, 2025, View Source [SID1234659848])